1. Home
  2. VLY vs HALO Comparison

VLY vs HALO Comparison

Compare VLY & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Valley National Bancorp

VLY

Valley National Bancorp

N/A

Current Price

$12.84

Market Cap

7.6B

Sector

Finance

ML Signal

N/A

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

N/A

Current Price

$70.88

Market Cap

8.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VLY
HALO
Founded
1927
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.6B
8.8B
IPO Year
N/A
2001

Fundamental Metrics

Financial Performance
Metric
VLY
HALO
Price
$12.84
$70.88
Analyst Decision
Strong Buy
Buy
Analyst Count
13
11
Target Price
$13.69
$78.18
AVG Volume (30 Days)
8.9M
2.1M
Earning Date
01-01-0001
05-11-2026
Dividend Yield
3.41%
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.56
Revenue
N/A
$151,862,000.00
Revenue This Year
$23.47
$28.38
Revenue Next Year
$8.43
$12.72
P/E Ratio
$13.14
$27.52
Revenue Growth
N/A
N/A
52 Week Low
$7.48
$47.50
52 Week High
$13.87
$82.22

Technical Indicators

Market Signals
Indicator
VLY
HALO
Relative Strength Index (RSI) 49.79 40.55
Support Level $10.32 $67.94
Resistance Level $13.87 $74.92
Average True Range (ATR) 0.40 2.54
MACD -0.10 -1.21
Stochastic Oscillator 11.26 4.55

Price Performance

Historical Comparison
VLY
HALO

About VLY Valley National Bancorp

Valley National Bancorp is a bank holding company that offers a full suite of national and regional banking solutions through various commercial, private banking, retail, insurance, and wealth management financial services products. It provides personalized service and customized solutions to assist its customers with their financial service needs. The group also offers niche financial services, including loan and deposit products for homeowners associations, cannabis-related business banking, and venture banking, which offers nationally. It manages its business operations under operating segments consisting of Consumer Banking; Commercial Banking; and Treasury and Corporate Other. The group generates the majority of its revenue from the Commercial Banking Segment.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: